Review Article

Role of the Arylhydrocarbon Receptor (AhR) in the Pathology of Asthma and COPD

Figure 1

Effects of AhR agonist B[a]P on MUC5AC mRNA level in NCI-H292 after 12 h of incubation. MUC5AC was measured by real-time RT-PCR. B[a]P induced MUC5AC mRNA expression in dose-dependent manner. Pretreatment with AhR antagonist, resveratrol, inhibited AhR-induced MUC5AC upregulation. Data are expressed as means ± SD . versus control (medium alone). versus B[a]P 1 μM.
372384.fig.001